Author details

Full Name

Lorelei A Mucci

Affiliation

ORCID

Career Start Year

2000

Papers

442

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37909946	Adiposity, Weight Change, and Urinary Melatonin Levels among Men in the Multiethnic Cohort.	Cancer Epidemiol Biomarkers Prev	2024
37856781	SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.	Carcinogenesis	2024
34969655	p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-up.	Eur Urol Oncol	2023
36018819	Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men.	Hum Mol Genet	2023
35637041	A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer.	Eur Urol	2023
36125519	Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions.	Mol Cancer Res	2023
35726641	Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis.	Int J Epidemiol	2023
37945903	Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.	Nat Genet	2023
37733366	Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.	JAMA Oncol	2023
37898724	Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy.	Br J Cancer	2023
37555839	Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study.	Cancer Epidemiol Biomarkers Prev	2023
37348500	Integrating genetics and metabolomics from multi-ethnic and multi-fluid data reveals putative mechanisms for age-related macular degeneration.	Cell Rep Med	2023
36719725	Promoting Reproducibility and Integrity in Observational Research: One Approach of an Epidemiology Research Community.	Epidemiology	2023
37087528	Relationship between cigarette use and prostate cancer risk: what do we know and what should we do?		2023
37086362	ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer.	Support Care Cancer	2023
36511902	The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer.	Mol Cancer Res	2023
37462694	Association between Outdoor Light at Night and Prostate Cancer in the Health Professionals Follow-up Study.		2023
37202314	2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.	Eur Urol	2023
37139568	Influence of Neighborhood Social and Natural Environment on Prostate Tumor Histology in a Cohort of Male Health Professionals.	Am J Epidemiol	2023
36490225	Prospective Study of Avocado Consumption and Cancer Risk in U.S. Men and Women.	Cancer Prev Res (Phila)	2023
37129148	Proportion and number of cancer cases and deaths attributable to behavioral risk factors in Vietnam.	Int J Cancer	2023
37384841	Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial.		2023
37125486	The Imperative for Population-based Cancer Registration of All Metastatic Cancers.		2023
37311464	Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.	Am J Hum Genet	2023
37249585	Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer.	Cancer Epidemiol Biomarkers Prev	2023
37246339	Experience with the US health care system for Black and White patients with advanced prostate cancer.	Cancer	2023
36861107	Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer.	Eur Urol Open Sci	2023
37428996	Aggressive Prostate Cancer Is Preventable and so Are Racial Disparities.	J Clin Oncol	2023
37292833	Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.	medRxiv	2023
36453265	Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer.	J Urol	2023
37500788	Different operationalizations of the 2018 WCRF/AICR cancer prevention recommendations and risk of cancer.	Br J Cancer	2023
34475523	Racial disparities in prostate cancer among black men: epidemiology and outcomes.	Prostate Cancer Prostatic Dis	2022
35522215	Regular, Long-Duration Multivitamin Use and Risk of Overall and Aggressive Prostate Cancer in the Health Professionals Follow-Up Study.	J Urol	2022
35391539	Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes.	Diabetologia	2022
36103261	Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years.	Clin Cancer Res	2022
35836303	The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy.	J Pathol Clin Res	2022
36028533	Post-diagnostic health behaviour scores in relation to fatal prostate cancer.	Br J Cancer	2022
35579976	Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia.	Int J Cancer	2022
36332173	IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.	JCO Glob Oncol	2022
36326979	Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study.	Eur J Epidemiol	2022
36125434	Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?	Cancer Prev Res (Phila)	2022
35670774	The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.	Clin Cancer Res	2022
35603853	Long-Term Survival and Causes of Death After Diagnoses of Common Cancers in 3 Cohorts of US Health Professionals.	JNCI Cancer Spectr	2022
33792693	Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.	J Natl Cancer Inst	2022
34626297	Aspirin use and prostate tumor angiogenesis.	Cancer Causes Control	2022
35292800	Validity and Relative Validity of Alternative Methods of Assessing Physical Activity in Epidemiologic Studies: Findings From the Men's Lifestyle Validation Study.	Am J Epidemiol	2022
34792282	Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.	Mol Oncol	2022
34791008	Association of plant-based diet index with prostate cancer risk.	Am J Clin Nutr	2022
35255255	Impact of neighborhood socioeconomic status, income segregation, and greenness on blood biomarkers of inflammation.	Environ Int	2022
35255119	5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care.	Cancer Epidemiol Biomarkers Prev	2022